Zacks Investment Research upgraded shares of Marathon Patent Group Inc. (NASDAQ:MARA) from a sell rating to a hold rating in a report released on Wednesday morning.

According to Zacks, “Marathon Patent Group Inc. is a patent and patent rights acquisition and licensing company. The Company acquires patents from a wide-range of patent holders from individual inventors to Fortune 500 companies. It serves its clients through two complementary business units: IP Services and IP Licensing and Enforcement business. Marathon Patent Group, Inc. is based in Alexandria, Virginia. “

Marathon Patent Group (NASDAQ:MARA) opened at 1.81 on Wednesday. The stock has a 50 day moving average price of $2.23 and a 200 day moving average price of $2.63. Marathon Patent Group has a 12 month low of $1.29 and a 12 month high of $3.44. The stock’s market capitalization is $27.28 million.

Marathon Patent Group (NASDAQ:MARA) last released its earnings results on Monday, November 14th. The company reported ($0.42) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.25) by $0.17. Marathon Patent Group had a negative net margin of 14.15% and a negative return on equity of 10.36%. Equities analysts predict that Marathon Patent Group will post ($0.23) EPS for the current fiscal year.

WARNING: This report was published by Financial Market News and is the propert of of Financial Market News. If you are viewing this report on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The legal version of this report can be read at http://www.financial-market-news.com/marathon-patent-group-inc-mara-upgraded-by-zacks-investment-research-to-hold/1212533/.

Several institutional investors have recently added to or reduced their stakes in MARA. Eagle Global Advisors LLC purchased a new position in Marathon Patent Group during the third quarter valued at about $118,000. Vanguard Group Inc. increased its position in Marathon Patent Group by 3.5% in the second quarter. Vanguard Group Inc. now owns 204,734 shares of the company’s stock valued at $561,000 after buying an additional 6,900 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. increased its position in Marathon Patent Group by 17.5% in the second quarter. Cambridge Investment Research Advisors Inc. now owns 848,449 shares of the company’s stock valued at $2,325,000 after buying an additional 126,565 shares during the last quarter. 9.41% of the stock is currently owned by hedge funds and other institutional investors.

Marathon Patent Group Company Profile

Marathon Patent Group Inc (MARA) is engaged in acquiring patents and patent rights from owners or other ventures. The Company monetizes its portfolio of patents and patent rights by entering into license discussions. The Company owns around 378 United States and foreign patents, and patent rights across a range of technologies and markets.

5 Day Chart for NASDAQ:MARA

Get a free copy of the Zacks research report on Marathon Patent Group (MARA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Marathon Patent Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marathon Patent Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.